Metabolic and bone profile in postmenopausal women with and without type 2 diabetes: a cross-sectional study

Open access

Abstract

Introduction. Current studies support the implication of metabolic changes associated with type 2 diabetes in altering bone metabolism, structure and resistance.

Objective. We conducted a cross-sectional study on postmenopausal women aimed to analyze the differences in metabolic and bone profile in patients with and without type 2 diabetes

Methods. We analyzed the metabolic and bone profile in postmenopausal women with and without type 2 diabetes (T2DM). Clinical, metabolic, hormonal parameters, along with lumbar, hip and femoral bone mineral density (BMD) and trabecular bone score (TBS) were evaluated.

Results. 56 women with T2DM(63.57±8.97 years) and 83 non-T2DM (60.21±8.77 years) were included. T2DM patients presented a higher value of body mass index (BMI) and BMD vs. control group (p = 0.001; p = 0.03-lumbar level, p = 0.07-femoral neck and p = 0.001-total hip). Also, BMI correlated positively with lumbar-BMD and glycated hemoglobin (HbA1c) (r = 0.348, p = 0.01; r = 0.269, p = 0.04), correlation maintained even after age and estimated glomerular filtration rate (eGFR) adjustment (r = 0.383, p = 0.005; r = 0.237, p = 0.08). Diabetic patients recorded lower levels of 25(OH)D(p = 0.05), bone markers (p ≤ 0.05) and TBS(p = 0.07).

For the entire patient group we found a negative correlation between HbA1c level and bone markers: r = -0.358, p = 0.0005-osteocalcin, r = -0.40, p = 0.0005-P1NP, r = -0.258, p = 0.005-crosslaps.

Conclusions. Our results indicate the presence of altered bone microarchitecture in T2DZ patients according to the TBS score, combined with lower levels of bone markers, with a statistically significant negative correlation between HbA1c level and bone markers.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. LIU JIAN-MIN ROSEN J. CLIFFORD DUCY PATRICIA KOUSTENI STAVROULA KARSENTY GERARD. Regulation of glucose handling by the skeleton: insights from mouse and human studies. Diabetes (2016); 65:3225–3232.

  • 2. SANCHES CP VIANNA AGD BARRETO F DE C. The impact of type 2 diabetes on bone metabolism. Diabetology & Metabolic Syndrome. 2017;9:85.

  • 3. CLEMENS T. L. KARSENTY G. The osteoblast: An insulin target cell controlling glucose homeostasis. J Bone Miner Res (2011) 26:677-680.

  • 4. FERRON M WEI J YOSHIZAWA T et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010; 142(2): 296-308.

  • 5. MATTHEW P. GILBERT RICHARD E. PRATLEY. The impact of diabetes and diabetes medications on bone health. Endocrine Reviews (2015);36(2):194–213.

  • 6. ZOCH ML CLEMENS TL RIDDLE RC. New insights into the biology of osteocalcin. Bone. 2016;82:42-49.

  • 7. FAIENZA MF LUCE V VENTURA A et al. Skeleton and glucose metabolism: a bone-pancreas loop. International Journal of Endocrinology (2015); 2015:758148.

  • 8. SHAO J WANG Z YANG T YING H ZHANG Y LIU S. Bone regulates glucose metabolism as an endocrine organ through osteocalcin. International Journal of Endocrinology. 2015;2015:967673.

  • 9. AMERICAN DIABETES ASSOCIATION. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes – 2018. Diabetes Care 2018;41(Suppl. 1):S13-S27.

  • 10. COMPSTON J. Type 2 diabetes mellitus and bone (Review). J Intern Med 2018; 283: 140-153.

  • 11. DUMITRU N. COCOLOS A. CARAGHEORGHEOPOL A. DUMITRACHE C. BRATU O.G NEAGU T.P DIACONU C.C GHEMIGIAN A. Collagen – the ultrastructural element of the bone matrix. Rev.Chim. (Bucharest) 2018 69(No. 7) 1706-1709.

  • 12. MOREIRA C.A. BARRETO F.C. DEMPSTER D.W. New insights on diabetes and bone metabolism. Brazilian Journal of Nephrology (2015) 37(4): 490-495.

  • 13. CARNEVALE V. ROMAGNOLI E. D’ERASMO L. D’ERASMO E. Bone damage in type 2 diabetes mellitus. Nutrition Metabolism and Cardiovascular Diseases. 2014;24 (11): 1151-1157.

  • 14. JACKULIAK P.; PAYER J. Osteoporosis Fractures and Diabetes. International Journal of Endocrinology vol. 2014 Article ID 820615 10 p. 2014.

  • 15. DEDE A.D. TOURNIS S. DONTAS I. TROVAS G. Type 2 diabetes mellitus and fracture risk. Metabolism – Clinical and Experimental 2014 63(12): 1480-1490.

  • 16. OEI L ZILLIKENS MC DEHGHAN A et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam study. Diabetes Care. 2013;36(6):1619-1628.

  • 17. RUBIN M.R. Skeletal fragility in diabetes. Ann. N.Y. Acad. Sci. 2017 1402: 18-30.

  • 18. KARIM L BOUXSEIN ML. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties. Bone. 2016;82:21-27.

  • 19. SUNDARARAGHAVAN V MAZUR MM EVANS B LIU J EBRAHEIM NA. Diabetes and bone health: latest evidence and clinical implications. Therapeutic Advances in Musculoskeletal Disease. (2017);9(3):67-74.

  • 20. DUMITRU N. CARSOTE M. COCOLOS A. GHEMIGIAN A. Glucose metabolism indices and Trabecular Bone Score in type 2 diabetes mellitus women. 4th International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complication INTERDIAB Conference Proceedings Volume 2018 117-125.

  • 21. SILVA B.C BROY S.B BOUTROY S. SCHOUSBOE J.T. SHEPHERD J.A. LESLIE W.D. Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. J Clin Densitom. 2015;18(3):309-330.

  • 22. WORLD HEALTH ORGANISATION. Global Report on Diabetes. World Health Organisation 2016.

  • 23. KREMER R. GILSANZ V. Fat and bone: an odd couple. Frontiers in Endocrinology. 2016;6:190.

  • 24. WALSH J.S VILACA T. Obesity type 2 diabetes and bone in adults. Calcified Tissue International. 2017;100(5):528-535.

  • 25. MOSELEY KF. Type 2 diabetes and bone fractures. Current opinion in endocrinology diabetes and obesity. 2012;19(2):128-135.

  • 26. IPPEI KANAZAWA. Interaction between bone and glucose metabolism [Review]. Endocrine Journal 2017; 64(11): 1043-1053.

  • 27. YONG JUN CHOI SO YOUNG OCK YOON-SOK CHUNG. Trabecular bone score (TBS) and TBS-adjusted fracture risk assessment tool are potential supplementary tools for the discrimination of morphometric vertebral fractures in postmenopausal women with type 2 diabetes. Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health 2016; 19(4): 507-514.

  • 28. STARUP-LINDE J. VESTERGAARD P. Biochemical bone turnover markers in diabetes mellitus – a systemaic review. Bone 2016;82:69-78.

  • 29. HYGUM K. STARUP-LINDE J. HARSLØF T. VESTERGAARD P. LANGDAHL B.L. Mechanisms in endocrinology: diabetes mellitus a state of low bone turnover – a systematic review and meta-analysis. Eur. J. Endocrinol. 2017;176:R137-R157.

  • 30. VIANNA A.G.D SNACHES C.P BARRETO F.C. Review article: effects of type 2 diabetes therapies on bone metabolism. Diabetology & Metabolic Syndrome. 2017;9:75.

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 429 429 51
PDF Downloads 223 223 29